Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael S Magee

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Discovery Medicine|November 27, 2014
Challenges to chimeric antigen receptor (CAR)-T cell therapy for cancerMichael S Magee, Adam E Snook
Immunologic Research|November 1, 2011
GUCY2C-targeted cancer immunotherapy: past, present and futureAdam E Snook, Michael S Magee, Scott A Waldman
Discovery Medicine|June 4, 2013
Colorectal cancer immunotherapyBo Xiang, Adam E Snook, Michael S Magee, et al.
European Journal of Immunology|April 29, 2014
Selective antigen-specific CD4(+) T-cell, but not CD8(+) T- or B-cell, tolerance corrupts cancer immunotherapyAdam E Snook, Michael S Magee, Stephanie Schulz, et al.
Biomarkers in Medicine|February 8, 2013
Immunotherapeutic strategies to target prognostic and predictive markers of cancerMichael S Magee, Adam E Snook, Glen P Marszalowicz, et al.
Cancer Immunology, Immunotherapy : CII|November 8, 2011
Epitope-targeted cytotoxic T cells mediate lineage-specific antitumor efficacy induced by the cancer mucosa antigen GUCY2CAdam E Snook, Michael S Magee, Glen P Marszalowicz, et al.
International Journal of Radiation Oncology, Biology, Physics|March 26, 2014
Tumor radiation therapy creates therapeutic vaccine responses to the colorectal cancer antigen GUCY2CMatthew Witek, Erik S Blomain, Michael S Magee, et al.
Oncotarget|October 9, 2014
GUCY2C lysosomotropic endocytosis delivers immunotoxin therapy to metastatic colorectal cancerGlen P Marszalowicz, Adam E Snook, Michael S Magee, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 26, 2017
Prime-Boost Immunization Eliminates Metastatic Colorectal Cancer by Producing High-Avidity Effector CD8<sup>+</sup> T CellsBo Xiang, Trevor R Baybutt, Lisa Berman-Booty, et al.
Plos One|August 8, 2014
A novel CDX2 isoform regulates alternative splicingMatthew E Witek, Adam E Snook, Jieru E Lin, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Discovery Medicine|November 27, 2014
Challenges to chimeric antigen receptor (CAR)-T cell therapy for cancerMichael S Magee, Adam E Snook
Immunologic Research|November 1, 2011
GUCY2C-targeted cancer immunotherapy: past, present and futureAdam E Snook, Michael S Magee, Scott A Waldman
Discovery Medicine|June 4, 2013
Colorectal cancer immunotherapyBo Xiang, Adam E Snook, Michael S Magee, et al.
European Journal of Immunology|April 29, 2014
Selective antigen-specific CD4(+) T-cell, but not CD8(+) T- or B-cell, tolerance corrupts cancer immunotherapyAdam E Snook, Michael S Magee, Stephanie Schulz, et al.
Biomarkers in Medicine|February 8, 2013
Immunotherapeutic strategies to target prognostic and predictive markers of cancerMichael S Magee, Adam E Snook, Glen P Marszalowicz, et al.
Cancer Immunology, Immunotherapy : CII|November 8, 2011
Epitope-targeted cytotoxic T cells mediate lineage-specific antitumor efficacy induced by the cancer mucosa antigen GUCY2CAdam E Snook, Michael S Magee, Glen P Marszalowicz, et al.
International Journal of Radiation Oncology, Biology, Physics|March 26, 2014
Tumor radiation therapy creates therapeutic vaccine responses to the colorectal cancer antigen GUCY2CMatthew Witek, Erik S Blomain, Michael S Magee, et al.
Oncotarget|October 9, 2014
GUCY2C lysosomotropic endocytosis delivers immunotoxin therapy to metastatic colorectal cancerGlen P Marszalowicz, Adam E Snook, Michael S Magee, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 26, 2017
Prime-Boost Immunization Eliminates Metastatic Colorectal Cancer by Producing High-Avidity Effector CD8<sup>+</sup> T CellsBo Xiang, Trevor R Baybutt, Lisa Berman-Booty, et al.
Plos One|August 8, 2014
A novel CDX2 isoform regulates alternative splicingMatthew E Witek, Adam E Snook, Jieru E Lin, et al.
Pageof 2